Title
A phase I dose escalation study of STEMVAC, a multi-antigen, multi-epitope Th1 selective plasmid-based vaccine, targeting stem cell associated proteins in patients with advanced breast cancer
Document Type
Presentation
Publication Date
11-9-2022
Keywords
oregon; portland; chiles
Clinical Institute
Cancer
Clinical Institute
Women & Children
Department
Oncology
Recommended Citation
Stanton, S, "A phase I dose escalation study of STEMVAC, a multi-antigen, multi-epitope Th1 selective plasmid-based vaccine, targeting stem cell associated proteins in patients with advanced breast cancer" (2022). Articles, Abstracts, and Reports. 6990.
https://digitalcommons.providence.org/publications/6990
Comments
SITC Annual Meeting; 2022 November 9; Boston, MA.